The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Webcast
Continuing from Part 1, this short session updates supply chain professionals on the design and timing of the new small bore tubing connectors maki
On-Demand Educational Webinars
This webinar provides an overview of the reasons for drug shortages, recent advocacy efforts to ameliorate the situation, and action steps…
Webcast
in this short video webcast, Mike Schiller, Senior Director, AHRMM and Dennis Othman, Senior Director, SMI discuss the four key pillars of knowledg
Podcasts
In this three-part webcast, Howard Mann, Vice President, Supply Chain Management at Cardiovascular Care Group discusses the basics and relationship
Book
AHRMM created this book for engaged and motivated supply chain leaders in the making.
On-Demand Educational Webinars
As hospitals restructure to gain sustainability in an era of reform, it is crucial for supply chain leaders to work collaboratively within health…